Heads up. Pharmac is considering two key changes in the provision of Covid vaccines, effective 2026:
- Lifting the age criteria for 6 monthly funded additional doses from 30+ to 50+ (plus targeted groups).
- Private vaccines for those that fall outside the criteria.
1/
Pharmac has sent out an RFP for supply of Covid vaccines from 1 February 2026 until 30 September 2027, with possible extensions until 30 September 2029.
Any changes to eligibility would be subject to consultation and likely not take effect until 2026. 2/ pharmac.govt.nz/news-and-resou…
Instead of funding additional doses every 6 months for those aged 30+, additional doses would be available every 6 months for:
- all people aged 50 years and over;
- pregnant people;
- people with serious mental health conditions;
- people with a BMI of 35 or over;
3/
- disabled people with significant or complex health needs, including those who receive Ministry of Disabled People | Whaikaha Disability Support Services;
- people aged 12 years and over with a medical condition that increases the risk of severe illness from COVID-19.
4/
‘The clinical advice we received in relation to the proposed eligibility criteria was for a slightly narrower group of people, specifically all people aged 65 years and over, and Māori and Pacific people from 50 years and over.’
5/
‘We are proposing to widen this to include all people aged 50 years and over to allow targeted implementation to other groups who may be experiencing health disparities.’
6/
Pharmac is also suggesting a private vaccine market for those who do not meet the eligibility criteria, as happens with the influenza vaccine market.
IMAC made a similar suggestion in its March 2024 advice to Pharmac.
IMAC, March 2024:
"The Committee considered it would be advantageous for people not eligible for funded [COVID-19] vaccines to have the option to purchase vaccines if they wished. It it is suppliers who will decide whether they will support a private market for vaccines." 8/
@threadreaderapp unroll
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Actor @MattMcGorry shares the devastating impact of long Covid.
This is so well told and well referenced. Thank you for sharing this important story and raising awareness.
Part 1 of 4
2 mild infections April 2022 and April 2023.
18 months later Matt has never fully recovered.
Matt McGorry #longcovid story
Part 2 of 4 talks more about his symptoms including dysautonomia, brain fog, sleep difficulties, Raynaud's syndrome and a vascular lesion.
Matt also suggests that many people are in denial that they have long Covid. Hard agree.
Matt McGorry #longcovid
Part 3 of 4: Matt has endothelial dysfunction, damage to the inner lining of his blood vessels - all 60,000 miles of them
Federal officials said temperatures above 104°F made it difficult for workers to wear the required full-body suits, goggles & N95 masks for protection.
Large-scale industrial fans were used to help cool the barns, but also spread feathers around, which are known to carry virus.
Direct exposure to infected birds increases the risk of contracting the disease because birds shed flu viruses in their saliva, mucous and faeces.
Despite growing up in the limelight, the teen has maintained a modicum of silence, but reportedly decided to speak out publicly to quash the persistent speculation around her prolific mask wearing, and the accusations of 'hypochondria.' #VioletAffleck
'Her parents support her on whatever she chooses to do and were able to pull some strings to get her in front of the LA County Board of Supervisors. They are proud of her.' #VioletAffleck
Excellent article on all things Covid with useful facts from @AmandaKvalsvig and @DrAnnaNZ on the risks of Covid and the need to do more to prevent infections.
Balanced by some less helpful quotes from the usual suspects.
An exciting discovery! There’s a way to boost antibodies against Cov1d by sucking a lozenge.
A study found that Blis K12 S. salivarius oral probiotic boosts salivary anti-SARS-CoV-2 Spike IgG antibodies in vaccinated people via a process known as via molecular mimicry. 1/
Within two weeks of taking #BlisK12 probiotic, vaccinated participants showed increased antibody levels compared to controls or unvaccinated participants.
Participants took 50 mg (10^7 CFU) of Streptococcus salivarius K12 once per day before sleep.
2/
An earlier study from June 2021 found using 2 Blis K12 daily in 193 frontline medical staff:
- reduced the frequency of respiratory tract infections by 64.8%
- reduced the duration of respiratory tract infections and oral ulcer symptoms by 78%
Potentially concerning mutations in BA.2.86 descendant JN.1
“What is most intriguing about JN.1 and why I believe there is cause for concern is the striking amount of differences between it and the leading viruses today: XBB.1.5 & HV.1.” @WmHaseltine
JN.1 was identified in Luxembourg on August 25 2023 followed by England, Iceland, France & the US. In GISAID there are 91 instances of JN.1 at the time of writing, suggesting hundreds if not thousands have been infected with JN.1 as sequencing efforts have been largely halted.
2/
The XBB.1.5 variant is the target of the latest vaccine boosters. Most emerging variants are descendants of XBB.1.5.
HV.1 is a relative newcomer and boasts a few differences from XBB.1.5 but is mainly similar to XBB.1.5.
3/